Related Experiment Video
Updated: May 20, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Vismodegib in basal cell carcinoma
R N Amaria1, D W Bowles, K D Lewis
1Cutaneous Malignancies and Developmental Therapeutics Programs, University of Colorado Cancer Center, Aurora, Colorado 80045, USA.
Abstract:
Vismodegib is a novel, small-molecule inhibitor of smoothened, a key component of the hedgehog signaling pathway. Increased hedgehog pathway signaling is critical in the development of hereditary and spontaneous basal cell carcinomas of the skin, and has been implicated in the development of a number of other tumors. In preclinical models, vismodegib demonstrated potent antitumor activity in hedgehog-dependent tumors, particularly basal cell carcinomas. Clinically, phase I and II studies showed dramatic anticancer activity in patients with advanced basal cell carcinomas. In January 2012, vismodegib was approved by the FDA for the treatment of unresectable or metastatic basal cell carcinomas of the skin.
Insights
Vismodegib effectively targets the hedgehog pathway, showing significant antitumor activity in preclinical and clinical studies for advanced basal cell carcinoma. This drug is now FDA-approved for treating unresectable or metastatic skin cancers.
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Hedgehog signaling pathway activation is crucial in basal cell carcinoma (BCC) development.
- Vismodegib is a novel small-molecule inhibitor targeting smoothened (SMO), a key component of this pathway.
- Aberrant hedgehog signaling is implicated in various other tumor types.
Purpose of the Study:
- To evaluate the efficacy and safety of vismodegib in preclinical models and clinical trials for BCC.
- To establish vismodegib as a targeted therapy for advanced basal cell carcinomas.
Main Methods:
- Preclinical studies in animal models assessing antitumor activity.
- Phase I and II clinical trials in patients with advanced basal cell carcinomas.
- FDA review and approval process for a novel cancer therapeutic.
Main Results:
- Vismodegib demonstrated potent antitumor activity in hedgehog-dependent tumors, especially BCCs, in preclinical settings.
- Clinical studies revealed dramatic anticancer responses in patients with advanced BCC.
- FDA approval in January 2012 for specific indications.
Conclusions:
- Vismodegib represents a significant advancement in targeted therapy for basal cell carcinoma.
- The drug offers a new treatment option for patients with unresectable or metastatic BCC.
- Targeting the hedgehog pathway is a validated strategy for treating certain skin cancers.
More Related Videos
09:37Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
06:34SCAnED - An Open-source Skin Segmentation Macro for Semi-automated Cell and Nuclei Detection in Epidermal and Dermal Skin Compartments
Published on: August 8, 2025
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Papillary Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...
Cells of the Epidermis
The cells in all these layers except the stratum basale are called keratinocytes, a type of cell that manufactures and stores the protein keratin. The keratinocytes in the stratum corneum are dead and regularly slough away, being replaced by cells from...
Cancer Cell Migration through Invadopodia
Cellular Adaptation IV: Dysplasia and Metaplasia
Clinical Applications of Epidermal Stem Cells